The Hereditary Neuropathy Foundation (HNF) proudly announces its new national network designating medical Centers of Excellence (COE) for the hereditary neuropathy patient community.  The designated COEs   demonstrate strengths in providing excellence in clinical care and research and will collaborate with HNF to expand their role as CMT/IN patient community hubs forclinical care, community engagement, research, and training/education. 

**Pharnext announced the opening of the first two U.S. trial sites for its PLEO-CMT pivotal Phase 3 clinical trial of its lead pleodrug PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A). Locations noted in red below.


WASHINGTON

St. Luke’s Rehabilitation Institute
St. Luke’s Physiatry Practice
715 South Cowley Street, Suite 210
Spokane, WA  99202

Contact:
Falishia Solano
Phone:  509-473-6706

NEW YORK

Currently accepting patients

Columbia University
Department of Neurology
710 West 168th Street
New York, NY  10032

Contact:
For clinical appointments
Phone: 212-305-0405
For research studies
Phone: 212-305-6035, ask for Allan Paras.


Share This